Michael Halpin
Chief Operating Officer presso VERICEL CORPORATION
Patrimonio netto: 49 367 $ in data 31/03/2024
Profilo
Michael Halpin is currently the Chief Operating Officer at Vericel Corp.
Prior to his current position, he held the role of Vice President-North American Region Regulatory at Genzyme Corp.
from 2002 to 2017.
He also worked as Vice President-North American Region Regulatory at Sanofi Corp.
Mr. Halpin completed his undergraduate and graduate degrees at the University of Virginia.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VERICEL CORPORATION
0.00% | 11/03/2024 | 949 ( 0.00% ) | 49 367 $ | 31/03/2024 |
Posizioni attive di Michael Halpin
Società | Posizione | Inizio |
---|---|---|
VERICEL CORPORATION | Chief Operating Officer | 15/06/2019 |
Precedenti posizioni note di Michael Halpin
Società | Posizione | Fine |
---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | - |
Sanofi Corp. | Corporate Officer/Principal | - |
Formazione di Michael Halpin
University of Virginia | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VERICEL CORPORATION | Health Technology |
Aziende private | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi Corp. |
- Borsa valori
- Insiders
- Michael Halpin